Inhibition of LXRα-Dependent Steatosis and Oxidative Injury by Liquiritigenin, a Licorice Flavonoid, as Mediated with Nrf2 Activation (Q39672749)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

13 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation (English)

1 reference

13 September 2017

Inhibition of LXRα-Dependent Steatosis and Oxidative Injury by Liquiritigenin, a Licorice Flavonoid, as Mediated with Nrf2 Activation (English)

1 reference

Crossref

DOI

10.1089/ARS.2010.3260

https://api.crossref.org/works/10.1089/ARS.2010.3260

15 June 2024

1 reference

6

Jee Woo Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20677908

15 June 2024

author name string

Young Woo Kim

1

1 reference

13 September 2017

Young Mi Kim

2

1 reference

13 September 2017

Yoon Mee Yang

3

1 reference

13 September 2017

Hee Yeon Kay

4

1 reference

13 September 2017

Won Dong Kim

5

1 reference

13 September 2017

Se Jin Hwang

7

1 reference

13 September 2017

Sang Geon Kim

8

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20677908

15 June 2024

publication date

1 November 2010

1 reference

13 September 2017

1 March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20677908

full work available at URL

15 June 2024

http://www.liebertpub.com/doi/pdf/10.1089/ars.2010.3260

1 reference

Crossref

DOI

10.1089/ARS.2010.3260

https://api.crossref.org/works/10.1089/ARS.2010.3260

Antioxidants & Redox Signaling

15 June 2024

published in

1 reference

13 September 2017

14

1 reference

13 September 2017

5

1 reference

13 September 2017

733-745

1 reference

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

13 September 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Effect of the dietary fat quality on insulin sensitivity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Role of phase 2 enzyme induction in chemoprotection by dithiolethiones

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Regulatory mechanisms controlling gene expression mediated by the antioxidant response element

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Pharmacokinetics of opioids in liver disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

The metabolic syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1089/ARS.2010.3260

Identifiers

DOI

10.1089/ARS.2010.3260

1 reference

13 September 2017

1 reference